Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US for the disease. The drug, known as voranigo, is used to treat a form of brain cancer, called IDH-mutated grade 2 glioma, in patients who have undergone surgery.
ENTRADAS POPULARES
Thousands protest in Valencia over lack of schools after floods
noviembre 25, 2024
COP29 agrees deal to kick-start global carbon credit trading
noviembre 25, 2024
The Girl with the Needle’ wins Camerimage’s Golden Frog
noviembre 25, 2024
TRANSMISIÓN EN VIVO